Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Galena Biopharma Inc. (GALE) Drops 5.17% on August 21

Galena Biopharma Inc. (GALE) was one of the Russell 2000's biggest losers for August 21 as the stock slid 5.17% to $2.20, a loss of $0.12 per share. Starting at an opening price of $2.27 a share, the stock traded between $2.12 and $2.28 over the course of the trading day. Volume was 3,965,404 shares over 5,957 trades.

The losses send Galena Biopharma Inc. down to a market cap of $260,051,363. 

For a full analysis of Galena Biopharma Inc., check out Equities.com's E.V.A. report.

One of the most effective tools for tracking the market for small-cap stocks is the Russell 2000, the nation's leading small-cap index created by industry stalwart Russell Investments. Unlike the well-known Dow Jones Industrial Average (DJIA) and S&P 500, Russell's indices eschew committee selection in favor of a more objective, rules-based system for selecting index membership.

The broad-based Russell 3000, which is meant to cover the stock market as a whole, is simply the 3,000 companies with the largest market cap in the United States. The Russell 2000 is then just the bottom 2,000 companies of that index, offering a look at those small-cap companies with smaller market caps. It makes for an unbiased overview of the small-cap stocks that can help any investor get a better sense of what the market is doing and where it might be headed.

For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.

All data provided by QuoteMedia and was accurate as of 4.30PM.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today